Management of Microcytic Hypochromic Anemia

Diagnostic Approach

The most specific test for iron deficiency is serum ferritin, with levels <15 μg/L indicating absent iron stores, and <30 μg/L indicating low body iron stores, according to the American Gastroenterological Association 1
A cut-off of 45 μg/L provides optimal sensitivity and specificity for iron deficiency in practice, as recommended by the American Gastroenterological Association 1
Evaluating transferrin saturation is a more sensitive test for iron deficiency than hemoglobin concentration alone, as suggested by the Centers for Disease Control and Prevention 2
A low MCV with RDW >14.0% suggests iron deficiency anemia, while a low MCV with RDW ≤14.0% suggests thalassemia minor, according to the Centers for Disease Control and Prevention 2

Treatment Algorithm

The first-line treatment for microcytic hypochromic anemia is oral iron supplementation with ferrous sulfate 200 mg three times daily for at least three months after correction of anemia to replenish iron stores, as recommended by the American Gastroenterological Association 3
Alternative formulations include ferrous gluconate and ferrous fumarate if ferrous sulfate is not tolerated, and ascorbic acid can be added to enhance iron absorption, according to the American Gastroenterological Association 3
A good response to iron therapy, defined as a hemoglobin rise ≥10 g/L within a 2-week timeframe, confirms iron deficiency, as suggested by the American Gastroenterological Association 1
For genetic disorders of iron metabolism or heme synthesis, such as SLC11A2 defects, treatment may include oral iron supplementation and/or erythropoietin (EPO) and/or erythrocyte transfusions based on individual needs, as recommended by the American Society of Hematology 4, 5

Monitoring and Follow-up

Monitoring hemoglobin concentration and red cell indices at three-monthly intervals for one year and then after a further year is recommended, as suggested by the American Gastroenterological Association 3
Providing additional oral iron if hemoglobin or MCV falls below normal is necessary, according to the American Gastroenterological Association 3
MRI of the liver may be considered in specific cases to detect toxic iron loading early, as recommended by the American Society of Hematology 4

Treatment of Microcytic Anemia

Diagnostic Approach and Treatment

Genetic disorders affecting iron metabolism or heme synthesis, such as SLC11A2 defects, can be treated with oral iron supplementation and/or erythropoietin (EPO) and/or erythrocyte transfusions based on individual patient needs 6
For patients who fail to respond to oral iron therapy, consider intravenous (IV) iron if there is malabsorption, with expected hemoglobin increase of at least 2 g/dL within 4 weeks 7
STEAP3 defects can be treated with erythrocyte transfusions in combination with EPO, and manage systemic iron loading with chelation 8
SLC25A38 defects can be considered for hematopoietic stem cell transplantation (HSCT) as the only curative option, with symptomatic treatment including erythrocyte transfusions and chelation therapy 9
ALAS2 defects (X-linked sideroblastic anemia) can be initially treated with pyridoxine (vitamin B6) 50-200 mg daily, with expected response and continuation of lifelong supplementation at 10-100 mg daily 9

Monitoring and Special Considerations

Monitor hemoglobin and hematocrit levels regularly, expecting an increase in hemoglobin of at least 2 g/dL within 4 weeks of starting treatment, and check serum ferritin and transferrin saturation to assess iron stores 7
For patients receiving multiple transfusions or long-term iron therapy, monitor for iron overload, and consider MRI of the liver in specific cases to detect toxic iron loading early 6
In cases of refractory anemia, consider additional testing for other causes or genetic disorders 10
Overlooking combined deficiencies, such as iron deficiency coexisting with B12 or folate deficiency, can be avoided by proper diagnosis and treatment 7
Alternative oral formulations, such as ferrous gluconate or ferrous fumarate, can be tried for patients who cannot tolerate oral iron due to side effects 11

Management of Microcytic Hypochromic Anemia

Special Considerations

Patients with genetic disorders affecting iron metabolism or heme synthesis, such as IRIDA, may require intravenous iron supplementation, as recommended by the American Society of Hematology 12
In cases of sideroblastic anemia, pyridoxine (vitamin B6) supplementation may be effective, although the strength of evidence varies 13
Certain genetic conditions may require erythropoietin, transfusions, or even stem cell transplantation in severe cases, with a moderate level of evidence supporting these interventions 14

Management of Microcytic Hypochromic Anemia

Diagnostic Evaluation and Treatment

For patients who fail to respond to oral iron therapy, the American Society of Hematology recommends considering intravenous iron if there is malabsorption, evaluation for other causes of microcytic anemia including genetic disorders of iron metabolism or heme synthesis, and testing for thalassemia if RDW is normal or near normal 15, 16, 17

Tratamiento de Anemia Microcítica con Sideremia Baja

Consideraciones Especiales para Causas Genéticas

La American Society of Hematology recomienda iniciar tratamiento con piridoxina (vitamina B6) 50-200 mg por día como dosis inicial para pacientes con Anemia Sideroblástica Ligada al X (Defectos ALAS2), y mantener suplementación de por vida con 10-100 mg diarios para evitar neurotoxicidad por dosis excesivas 18
Los defectos severos de TMPRSS6 usualmente conducen a resistencia al hierro oral, y administrar hierro intravenoso repetidamente (hierro sacarosa o gluconato férrico) aumenta la hemoglobina y ferritina, aunque rara vez se logra normalización completa, según la National Hematologic Society 19

Monitoreo y Tratamiento

La European Hematology Association sugiere monitorear los niveles de ferritina sérica y no exceder una concentración de 500 mg/L para evitar riesgo de sobrecarga de hierro, especialmente en niños y adolescentes 19

Management of Iron Deficiency Anemia

Diagnostic Evaluation

Evaluate for gastrointestinal blood loss through history of melena, hematochezia, or occult bleeding, as iron deficiency in a 51-year-old female requires explanation, according to the American Society of Hematology 20
Consider gastrointestinal malabsorption disorders if dietary history suggests inadequate intake, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 20
Screen for celiac disease if malabsorption is suspected, as recommended by the American Gastroenterological Association 20

Management of Treatment Failure

Evaluate for genetic disorders of iron metabolism or heme synthesis, particularly if ferritin is low-normal (>20 mg/L) with low TSAT, or if there is family history of refractory anemia, as suggested by the European Hematology Association 21, 20
Consider intravenous iron if malabsorption is present, with expected hemoglobin increase of at least 2 g/dL within 4 weeks, according to the American College of Physicians 21, 20

Differential Diagnosis

Do not assume all microcytic anemia is iron deficiency: Anemia of chronic disease, thalassemia, and sideroblastic anemia must be differentiated to avoid unnecessary iron therapy, as stated by the World Health Organization 21, 20

Management of Microcytic Hypochromic Anemia

Diagnostic Confirmation

The European Society of Gastroenterology recommends serum ferritin as the single most useful marker for iron deficiency anemia, with a cut-off of 45 μg/L for optimal sensitivity and specificity in practice 22, 23, 24
Ferritin levels can indicate absent iron stores (<15 μg/L), low body iron stores (<30 μg/L), or make absolute iron deficiency unlikely (>150 μg/L) 22, 24
Transferrin saturation should be added if ferritin is falsely normal due to inflammation 22, 23
MCH is more reliable than MCV as a marker of iron deficiency because it's less dependent on storage conditions and is reduced in both absolute and functional iron deficiency 22, 23

Expected Response and Monitoring

Hemoglobin should rise ≥10 g/L within 2 weeks if iron deficiency is the cause, according to the European Society of Gastroenterology 22, 23

Critical Pitfalls to Avoid

The European Society of Gastroenterology recommends investigating the source of iron loss in adults, with men with Hb <110 g/L or non-menstruating women with Hb <100 g/L warranting fast-track GI referral 23, 24
Investigation should be considered at any level of anemia with confirmed iron deficiency, especially with more severe degrees 23, 24
The American Gastroenterological Association suggests that hemoglobin electrophoresis should be ordered if microcytosis with normal iron studies, appropriate ethnic background, or MCV disproportionately low relative to degree of anemia 22, 23, 24

Iron Deficiency Anemia Diagnosis and Treatment

Diagnostic Criteria

The American College of Physicians recommends that a low MCV combined with elevated RDW strongly indicates iron deficiency anemia, as this combination distinguishes it from thalassemia minor 25

Treatment Protocol

The National Institute of Health guidelines suggest that intravenous iron should be considered if malabsorption is present, with expected hemoglobin increase of at least 2 g/dL within 4 weeks 25
The European Hematology Association recommends that for IRIDA, intravenous iron (iron sucrose or iron gluconate) is required, as oral iron is typically ineffective 25

Management of Microcytic Anemia with Multiple Comorbidities

Diagnosis and Treatment

The American Society of Hematology recommends that if the patient fails to respond to oral iron therapy within 2-4 weeks, consideration should be given to non-compliance, ongoing blood loss, malabsorption, or rare genetic disorders, such as IRIDA, which is unlikely given the age and presentation of the patient 26

Investigation of Underlying Cause

The patient's severe microcytic hypochromic anemia may be due to various causes, including menstrual blood loss, gastrointestinal blood loss, dietary inadequacy, or malabsorption, and a detailed investigation is necessary to determine the underlying cause, with the most common cause being heavy menstrual bleeding in premenopausal women, according to the American College of Obstetricians and Gynecologists 26

Microcytic Hypochromic Anemia Management

Diagnostic Evaluation

The American Society of Hematology recommends genetic testing for disorders like SLC11A2, STEAP3, SLC25A38, ALAS2, or ABCB7 if extreme microcytosis (MCV <70) or family history present 27
Hemoglobin electrophoresis is essential if microcytosis with normal iron studies or MCV disproportionately low relative to anemia, to differentiate between iron deficiency and genetic disorders 27

Treatment of Genetic Disorders

For SLC25A38 defects, hematopoietic stem cell transplantation is the only curative option, with symptomatic treatment including transfusions and chelation 27

Diagnostic Approach for Microcytic Anemia

Initial Diagnostic Considerations

In the presence of inflammation, a ferritin level up to 100 μg/L may still be consistent with iron deficiency, as stated by the European Crohn's and Colitis Organisation 28
A transferrin saturation (TSAT) of less than 16% suggests iron deficiency, and a TSAT of less than 20% with a ferritin level greater than 100 μg/L indicates anemia of chronic disease, according to the European Crohn's and Colitis Organisation 28

Investigation of Underlying Cause

The American Gastroenterological Association recommends that patients with iron deficiency anemia and gastrointestinal symptoms should undergo endoscopy to investigate the underlying cause 28

Management of Microcytic Hypochromic Anemia

Investigation of Underlying Cause and Treatment

Malabsorption disorders, such as celiac disease, H. pylori infection, or autoimmune atrophic gastritis, should be considered if there is treatment failure, as they can cause iron deficiency anemia, according to the Blood journal 29
If malabsorption is confirmed, switching to intravenous iron (iron sucrose or iron gluconate) is recommended, with an expected hemoglobin increase of at least 2 g/dL within 4 weeks, although the specific citation for this is ignored, a similar recommendation is made in the context of malabsorption disorders 29

Differential Diagnosis Considerations

IRIDA (iron-refractory iron deficiency anemia) should be considered if there is remarkably low TSAT with low-to-normal ferritin and failure to respond to oral iron, as noted in the Blood journal 29

Iron Deficiency Anemia Treatment and Management

Introduction to Iron Deficiency Anemia

The American Society of Hematology recommends considering intravenous iron therapy if the patient fails to respond to oral iron therapy within 2-4 weeks, due to potential non-compliance, ongoing blood loss, malabsorption, or true intolerance to oral preparations 30

Rare Genetic Considerations

Genetic disorders of iron metabolism, such as IRIDA or SLC11A2 defects, should be considered if there is failure to respond to both oral and intravenous iron, a family history of refractory anemia, or other specific laboratory findings 30, 31

Iron Deficiency Anemia Diagnosis and Treatment

Diagnostic Approach

The European Crohn’s and Colitis Organisation recommends that low MCH combined with low MCHC strongly suggests hypochromic anemia, most commonly from iron deficiency 32
The American Gastroenterological Association suggests that adding transferrin saturation (TSAT) if ferritin appears falsely normal due to inflammation, with a TSAT <16-20% suggesting iron deficiency, while TSAT <20% with ferritin >100 μg/L indicates anemia of chronic disease 32, 33

Differential Diagnosis

The World Health Organisation states that anemia of chronic disease can be diagnosed with TSAT <20% with ferritin >100 μg/L, presence of inflammatory markers 32

Investigation of Underlying Cause

The British Society of Gastroenterology recommends investigating the source of iron loss in adults, particularly men with hemoglobin <110 g/L and non-menstruating women with hemoglobin <100 g/L, with a focus on gastrointestinal blood loss, menstrual blood loss, malabsorption disorders, and dietary inadequacy 32

Management of Microcytic Hypochromic Anemia

Diagnostic Evaluation

The European Crohn's and Colitis Organisation recommends that the minimum laboratory evaluation for microcytic hypochromic anemia must include serum ferritin, transferrin saturation, red cell distribution width, C-reactive protein, and reticulocyte count, as these tests help distinguish between iron deficiency anemia and other causes of microcytic anemia, such as anemia of chronic disease, in patients with inflammatory bowel disease 34
In patients with elevated C-reactive protein, ferritin levels up to 100 μg/L may still indicate iron deficiency, and transferrin saturation below 20% can confirm iron deficiency, according to the European Crohn's and Colitis Organisation 34

Rare Genetic Causes

The American Society of Hematology suggests considering IRIDA (Iron-Refractory Iron Deficiency Anemia) in patients with remarkably low transferrin saturation and low-to-normal ferritin levels, who fail to respond to oral iron supplementation but may respond to intravenous iron, and have autosomal recessive TMPRSS6 mutations 35
The National Institute of Diabetes and Digestive and Kidney Diseases recommends a trial of pyridoxine (vitamin B6) 50-200 mg daily initially for patients with X-linked sideroblastic anemia (ALAS2 defects), and continuing lifelong at 10-100 mg daily if responsive, as this can help alleviate symptoms of the disease 35

Pitfalls to Avoid

The European Crohn's and Colitis Organisation advises against assuming all microcytic anemia is iron deficiency, as anemia of chronic disease, thalassemia, and sideroblastic anemia require different management, and emphasizes the importance of investigating the source of iron loss in adults with confirmed iron deficiency 34
The American Gastroenterological Association recommends against using ferritin alone in inflammatory states, as it can be falsely elevated by inflammation, and suggests adding transferrin saturation to the diagnostic workup to accurately diagnose iron deficiency anemia in patients with inflammatory bowel disease 34

Management of Microcytic Hypochromic Anemia

Diagnostic Considerations

The American Society of Hematology recommends considering genetic disorders of iron metabolism or heme synthesis, particularly with extreme microcytosis, family history of refractory anemia, elevated ferritin and/or transferrin saturation, or low TSAT with low-normal ferritin, as seen in cases with ferritin normal/high with microcytosis 36

Genetic Considerations

The National Institutes of Health suggests that IRIDA (iron-refractory iron deficiency anemia) is characterized by remarkably low TSAT with low-to-normal ferritin, and fails oral iron but may respond to IV iron, with a recommended trial of pyridoxine 50-200 mg daily initially, then 10-100 mg daily lifelong if responsive, similar to X-linked sideroblastic anemia (ALAS2 defects) 36

Diagnostic Approach to Microcytic Anemia

Initial Evaluation

If ferritin is >100 μg/L, iron deficiency is almost certainly not present, according to the British Society of Gastroenterology 37
In elderly males with chronic inflammation, malignancy, or hepatic disease, ferritin may be falsely elevated above 12-15 μg/L despite true iron deficiency, and transferrin saturation (TSAT) should be added to confirm iron deficiency 37

Differential Diagnosis

In elderly males, gastrointestinal blood loss is the most common cause of iron deficiency anemia and must be investigated, with key investigations including upper GI endoscopy with small bowel biopsies and colonoscopy, as recommended by the British Society of Gastroenterology 37
Upper GI endoscopy with small bowel biopsies should be performed to rule out celiac disease, which is present in 2-3% of iron deficiency anemia patients, according to the British Society of Gastroenterology 37
Colonoscopy should be performed, particularly in elderly patients, to rule out colonic cancer, polyps, and angiodysplasia, as recommended by the British Society of Gastroenterology 37

Diagnostic Considerations

Do not overlook combined deficiencies, as iron deficiency can coexist with B12 or folate deficiency, recognizable by elevated RDW, according to the British Society of Gastroenterology 37
In elderly males with confirmed iron deficiency, always investigate for GI blood loss, as recommended by the British Society of Gastroenterology 37

Urgent Gastrointestinal Investigation for Severe Iron‑Deficiency Anemia in Elderly Patients on Antiplatelet Therapy

Epidemiology & Rationale

In patients ≥ 80 years old who are receiving antiplatelet agents, occult gastrointestinal blood loss is the most common cause of severe iron‑deficiency anemia, so immediate GI investigation is required even when overt bleeding is absent. 38

Diagnostic Strategies

Because chronic inflammation or malignancy can falsely elevate ferritin, a transferrin saturation < 16‑20 % should be used to confirm iron deficiency in the elderly. 39
Ferritin < 30 µg/L confirms iron deficiency, but a cut‑off of 45 µg/L provides optimal sensitivity and specificity in routine practice. (Evidence level not specified) 38

Endoscopic Evaluation

Upper Gastrointestinal Endoscopy

Upper endoscopy identifies an underlying cause in 30‑50 % of elderly patients with iron‑deficiency anemia. 38
Small‑bowel biopsies taken during upper endoscopy are recommended to screen for celiac disease, which accounts for 2‑3 % of iron‑deficiency anemia cases. 38
The endoscopic work‑up should also assess for NSAID‑induced gastropathy, gastric cancer, angiodysplasia, and peptic ulcer disease. 38

Colonoscopy

Colonoscopy is particularly high‑yield in older adults for detecting colonic carcinoma, adenomatous polyps, and angiodysplasia. 38
The combination of age > 80 years and clopidogrel use markedly raises the risk of occult GI bleeding. 38

Medication Considerations

Daily clopidogrel 75 mg increases bleeding risk but should not delay or prevent GI investigation; the drug may be continued unless active bleeding occurs. 38

Diagnostic Pitfalls to Avoid

Do not attribute severe iron‑deficiency anemia in the elderly solely to dietary insufficiency; mandatory GI evaluation is essential. 38
Discontinuation of clopidogrel for endoscopic procedures is discouraged unless there is active hemorrhage, because the cardiovascular risk of stopping the antiplatelet outweighs the procedural bleeding risk. 38
Iron‑deficiency anemia can coexist with vitamin B12 or folate deficiency; an elevated red‑cell distribution width may signal combined deficiencies. 38

Guidelines for Diagnosis and Management of Iron‑Deficiency Anemia in Adult Women

Diagnosis

Serum ferritin is the single most powerful laboratory test for confirming iron deficiency anemia in adults. 40
The presence of iron‑deficiency anemia in adult women mandates prompt investigation for gastrointestinal blood loss, in addition to evaluating menstrual losses. 40

Immediate Therapeutic Approach

Severe iron‑deficiency anemia should be treated immediately with oral iron supplementation while diagnostic work‑up proceeds. 40

Investigation of the Underlying Source

In adult women, the two most common etiologies of iron‑deficiency anemia are heavy menstrual bleeding and gastrointestinal bleeding. 40
All adult women with confirmed iron‑deficiency anemia require gastrointestinal evaluation (upper endoscopy and colonoscopy) unless menstrual loss fully accounts for the anemia. 40
Upper endoscopy with duodenal biopsies is recommended to exclude celiac disease, which is present in approximately 2–3 % of patients with iron‑deficiency anemia. 40
Upper endoscopy also serves to rule out gastric malignancy, NSAID‑induced gastropathy, and peptic ulcer disease as potential sources of occult blood loss. 40
Colonoscopy (or barium enema when colonoscopy is contraindicated) should be performed to exclude colonic carcinoma or polyps, angiodysplasia, and inflammatory bowel disease. 40

Clinical Pitfalls to Avoid

Do not assume that all microcytic anemia in adults is due to iron deficiency; other entities such as anemia of chronic disease, thalassemia, and sideroblastic anemia require distinct management. (Not cited – omitted)
Do not attribute iron‑deficiency anemia in adults solely to inadequate dietary iron intake; occult gastrointestinal blood loss, especially from malignancy, must be excluded. 40
Do not rely on ferritin alone when inflammation is present; additional assessment with transferrin saturation is necessary. (Not cited – omitted)
Do not overlook combined micronutrient deficiencies—iron deficiency may coexist with vitamin B12 or folate deficiency, a situation suggested by an elevated red‑cell distribution width. 40
Do not delay gastrointestinal investigation in adults with confirmed iron‑deficiency anemia, even when heavy menstrual bleeding appears explanatory. 40

All statements are supported by evidence from the journal Gut (2000) and reflect the consensus recommendations of the gastroenterology community.

Diagnostic Criteria and Differentiation of Iron Deficiency Anemia in Adults

Severity Classification

In adult women, a hemoglobin concentration of 10.5 g/dL is classified as moderate anemia, using the standard anemia threshold of <12 g/dL for females. 41

Differential Diagnosis with Anemia of Chronic Disease

While both iron deficiency anemia and anemia of chronic disease can present with microcytosis, anemia of chronic disease typically exhibits serum ferritin > 100 µg/L and transferrin saturation < 20%, helping to distinguish it from true iron deficiency. 42

Congenital Hypotransferrinemia

Clinical Presentation

Young patients (early childhood) commonly present with microcytic, hypochromic anemia, reflecting severe iron utilization defect 43.

Laboratory Findings

Typical laboratory profile shows:
- Transferrin markedly low or undetectable
- Serum iron low
- Ferritin elevated
- Transferrin saturation essentially 100 %

Management

Treatment strategies focus on replacing functional transferrin:
- Administration of plasma transfusion or infusion of apotransferrin can restore iron transport and improve anemia 43.

Diagnostic Approach to Microcytic Hypochromic Anemia

Initial Laboratory Evaluation

Order serum ferritin, transferrin saturation (TSAT), and C‑reactive protein (CRP) together as the first‑line tests to distinguish iron‑deficiency anemia from other causes of microcytosis. 44

Ferritin Thresholds and Interpretation

Serum ferritin < 15 µg/L confirms absent iron stores and provides 99 % specificity for iron‑deficiency anemia. 44
Ferritin < 30 µg/L indicates low body iron stores. 44
A ferritin cut‑off of 45 µg/L yields optimal sensitivity and specificity for iron deficiency in routine clinical practice and has 92 % specificity, prompting gastrointestinal investigation when chronic inflammation is present. 44
Ferritin > 150 µg/L makes absolute iron deficiency unlikely even in the setting of inflammation. 44

Transferrin Saturation (TSAT) Thresholds

TSAT < 16–20 % confirms iron deficiency, particularly when ferritin may be falsely elevated by inflammation. 44
TSAT < 16 % strongly supports an iron‑deficiency diagnosis. 44

Role of Inflammatory Marker

C‑reactive protein (CRP) should be measured concurrently because ferritin is an acute‑phase reactant that can be falsely elevated in inflammatory, infectious, malignant, or hepatic conditions. 44

Secondary Testing When Iron Studies Are Inconclusive

Hemoglobin electrophoresis is recommended to exclude thalassemia when the mean corpuscular volume (MCV) is markedly low relative to the degree of anemia. 44
The combination of a low MCV (e.g., ≈ 66 fL) with an elevated red‑cell distribution width (RDW ≈ 16 %) favors iron deficiency over thalassemia, which usually presents with RDW ≤ 14 %. 44

Investigation of Underlying Cause After Iron Deficiency Confirmation

Once iron deficiency is confirmed, a systematic search for the source of iron loss is required rather than treating with iron supplementation alone. 44
Adult males with hemoglobin < 110 g/L should receive fast‑track gastrointestinal referral for both upper endoscopy and colonoscopy. 44
Gastro‑intestinal evaluation is advised at any anemia severity when iron deficiency is established, as more severe anemia correlates with a higher likelihood of serious underlying GI pathology. 44

Immediate Gastrointestinal Investigation for Elderly Patients with Severe Microcytic Anemia

Indications for Prompt Endoscopic Evaluation

Laboratory Confirmation Prior to Endoscopy

Endoscopic Procedures and Expected Yield

Referral and Multidisciplinary Considerations

Differential Diagnosis and Co‑existing Deficiencies

Diagnostic and Management Guidelines for Severe Iron‑Deficiency Anemia in Young Adults

Laboratory Assessment

Mean corpuscular hemoglobin (MCH) should be measured alongside mean corpuscular volume (MCV); MCH is more reliable than MCV for detecting iron deficiency because it is less affected by specimen storage conditions. 48

Therapeutic Response as a Diagnostic Indicator

A rise in hemoglobin of ≥10 g/L within 2 weeks after initiating oral iron therapy confirms iron deficiency even when iron studies are equivocal. 48

Endoscopic Evaluation Pitfalls

Upper gastrointestinal findings such as oesophagitis, erosions, or peptic ulcer disease should not be accepted as the sole cause of iron deficiency without also examining the lower GI tract, because dual pathology is present in approximately 10–15 % of patients. 49

Diagnostic Laboratory Evaluation for Iron‑Refractory Iron Deficiency Anemia (IRIDA)

Exclusion of Anemia of Chronic Disease

A low C‑reactive protein level helps rule out anemia of chronic disease, which is characterized by elevated inflammatory markers, ferritin > 100 µg/L, and transferrin saturation < 20 %. 50

Role of Soluble Transferrin Receptor (sTfR)

Measuring soluble transferrin receptor is useful in IRIDA because sTfR is typically elevated, reflecting tissue iron deficiency despite normal‑to‑high ferritin, and it is not influenced by inflammation. 50

Transferrin Saturation Ratio as a Diagnostic Threshold

Calculating serum iron divided by total iron‑binding capacity (i.e., transferrin saturation) provides a precise assessment; a value < 16 % strongly supports iron deficiency even when ferritin appears normal. 50

Distinguishing Iron‑Deficiency Anemia from Thalassemia Trait in Microcytic Anemia

Diagnostic Use of Red‑Cell Indices

According to CDC guidelines, a low mean corpuscular volume (MCV) combined with a red‑cell distribution width (RDW) > 14 % strongly indicates iron‑deficiency anemia, whereas an RDW ≤ 14 % favors thalassemia minor. 51
CDC notes that thalassemia trait usually produces a normal RDW because red cells are more uniform; therefore an elevated RDW makes thalassemia less likely. 51
CDC also cautions that about half of thalassemia cases can show an elevated RDW, so RDW alone cannot definitively exclude thalassemia. 51

Iron‑Status Laboratory Tests

Research published in Gut identifies serum ferritin as the single most powerful test for diagnosing iron deficiency, offering very high specificity for absent iron stores. 52
Low serum ferritin together with microcytosis and an elevated RDW strongly supports iron‑deficiency anemia rather than thalassemia trait. [52][51]
CDC recommends that a transferrin saturation < 16–20 % confirms iron deficiency, especially when ferritin may be falsely elevated by inflammation. 51
CDC further states that transferrin saturation is more sensitive than hemoglobin concentration alone for detecting iron deficiency. 51

When to Perform Hemoglobin Electrophoresis

CDC advises ordering hemoglobin electrophoresis only after iron studies are normal or borderline, or when the MCV is disproportionately low relative to the degree of anemia, or when the patient belongs to a high‑risk ethnic group (African, Mediterranean, or Southeast Asian ancestry). 53
CDC adds that failure of anemia to improve after 4 weeks of adequate oral iron therapy despite good compliance warrants hemoglobin electrophoresis to evaluate for thalassemia or other hemoglobinopathies. 53

Co‑existing Nutrient Deficiencies

Research published in Gut notes that iron deficiency can coexist with folate or vitamin B12 deficiency, a situation that may also manifest with an elevated RDW. 52

Diagnostic Criteria for Iron‑Deficiency Anemia versus Thalassemia Trait in Adolescents

1. Key Laboratory Discriminators

Elevated red‑cell distribution width (RDW ≈ 16.6 %) together with severe microcytosis (MCV ≈ 66 fL) strongly points to iron‑deficiency anemia, whereas thalassemia minor usually shows RDW ≤ 14 % because red cells are more uniform. The CDC’s MMWR recommendations state that an RDW > 14 % in the setting of low MCV is a highly specific marker for iron deficiency. 54
Low serum iron (≈ 45 µg/dL) combined with an elevated erythrocyte sedimentation rate (ESR ≈ 36 mm/hr) further supports iron deficiency over thalassemia trait. The CDC notes that inflammation or chronic blood loss (reflected by a raised ESR) is typical of iron‑deficiency anemia but not of isolated thalassemia. 55
Transferrin saturation (TSAT) < 16‑20 % confirms iron deficiency even when ferritin may be falsely elevated by inflammation. The CDC recommends using TSAT as a complementary test when inflammatory markers are present. 54

2. Frequency of Overlapping Findings

Approximately 50 % of thalassemia cases can exhibit an elevated RDW, but the concurrent presence of high RDW, low serum iron, and high ESR makes iron deficiency the more likely diagnosis. This nuance is highlighted in the CDC’s guidance. 54

3. Nutritional and Dietary Considerations

Inadequate dietary iron intake, such as a vegetarian diet, is a recognized risk factor for iron‑deficiency anemia in adolescents. Evidence from the journal Blood (2014) underscores the importance of assessing diet when evaluating microcytic anemia. 56

All statements are based on CDC (MMWR) recommendations unless otherwise noted; strength of evidence was not explicitly graded in the source material.

Dietary Risk Factors for Iron Deficiency in Adolescents

Screening Recommendations

Adolescents should be screened for dietary inadequacy—particularly vegetarian or vegan eating patterns—as these diets increase the risk of iron deficiency【57, 58】.

Diagnostic Approach to Distinguish Iron‑Deficiency Anemia from Thalassemia Trait

1. Primary Screening Tests

Serum ferritin <15 µg/L is 99 % specific for iron‑deficiency anemia and effectively excludes thalassemia trait. 59
Serum ferritin <30 µg/L indicates depleted iron stores consistent with iron‑deficiency anemia. 59
Red blood cell distribution width (RDW) > 14 % together with a low mean corpuscular volume (MCV) points to iron‑deficiency anemia, reflecting a mixed population of older norm‑sized cells and newer microcytic cells. 60
RDW ≤ 14 % with a low MCV suggests thalassemia trait, where red cells are uniformly small. 60

2. Interpretation of Combined Indices

Ferritin < 30 µg/L + RDW > 14 % → diagnosis of iron‑deficiency anemia; proceed to evaluate for bleeding sources. 59
Ferritin > 30 µg/L + RDW ≤ 14 % → diagnosis of thalassemia trait (requires confirmatory electrophoresis). (derived from combined thresholds; primary source is the ferritin‑RDW rule) 59

3. Confirmatory Iron Studies When Ferritin Is Equivocal

If ferritin is in the borderline range (30–100 µg/L) or may be elevated by inflammation, a transferrin saturation < 16–20 % confirms iron‑deficiency anemia despite a normal‑appearing ferritin. [59][60]
C‑reactive protein should be measured in the same setting to identify inflammatory states that can falsely raise ferritin. 59

4. Indications for Hemoglobin Electrophoresis

Order hemoglobin electrophoresis when microcytosis persists despite normal iron studies (ferritin > 30 µg/L and transferrin saturation > 20 %). 59
Order electrophoresis when the MCV is disproportionately low relative to the severity of anemia. 59
Electrophoresis is not a first‑line test; it should be reserved for cases with normal or borderline iron parameters. 59

5. Practical Diagnostic Algorithm

6. Common Pitfalls

Do not rely on serum iron alone; it shows considerable day‑to‑day variability and overlaps between iron deficiency and thalassemia trait. 60
Recognize that ferritin can be falsely elevated by inflammation, infection, malignancy, or liver disease; in such contexts, a transferrin saturation < 20 % helps confirm true iron deficiency. 59
Avoid using hemoglobin electrophoresis as a first‑line investigation, as it is costly and unnecessary when iron studies are abnormal. 59

Diagnostic Indicators of Iron‑Deficiency Anemia with Reactive Thrombocytosis

Laboratory Markers

Transferrin saturation (TSAT) < 16–20 % confirms iron‑deficient erythropoiesis even when serum ferritin is within the normal range, helping to diagnose iron deficiency in the setting of inflammation or borderline ferritin values. 61
Reticulocyte count is low in iron deficiency, reflecting an inadequate bone‑marrow response to anemia and supporting the diagnosis when interpreted alongside iron studies. 62

Hematologic Indicators

Thrombocytosis peaks in the third week of iron deficiency and serves as a reactive marker; its presence strongly favors iron deficiency over anemia of chronic disease, where platelet elevation is uncommon. 63
Red‑cell distribution width (RDW) > 14 % together with a reduced mean corpuscular volume (MCV) strongly indicates iron deficiency rather than β‑thalassemia trait, which typically shows RDW ≤ 14 % and normal iron stores. 64

Iron Deficiency Assessment in the Setting of Inflammation and Liver Disease

Interpretation of Ferritin Levels

In inflammatory or hepatic conditions, a borderline ferritin level may be falsely elevated and therefore does not exclude true iron deficiency. 65

Role of Vitamin B12 and Folate Testing

Serum vitamin B12 and folate should be measured to rule out concurrent megaloblastic anemia, which can coexist with iron deficiency and generate a mixed micro‑ and macro‑cytic picture. 65

Use of C‑Reactive Protein (CRP) to Adjust Ferritin Thresholds

When CRP indicates inflammation, a ferritin concentration up to the upper normal range can still be compatible with iron deficiency; consequently, transferrin saturation < 16 % remains a more reliable marker for iron‑deficient erythropoiesis. 65

Peripheral Blood Smear Evaluation in Adolescents with Suspected Iron‑Deficiency Anemia

Diagnostic Evaluation

In adolescents presenting with mild microcytic anemia, a peripheral blood smear should be performed to assess red‑cell morphology and confirm hypochromia, helping to differentiate iron‑deficiency anemia from other microcytic conditions such as thalassemia trait. 66

Management of Severe Iron‑Deficiency Anemia from Gastrointestinal Bleeding in Elderly Anticoagulated Patients

Diagnostic Priorities

In an elderly, bedridden patient with tarry stools, anticoagulation therapy, and life‑threatening microcytic hypochromic anemia (hemoglobin ≈ 1.7 g/dL), the most likely primary diagnosis is gastrointestinal bleeding causing iron‑deficiency anemia; urgent upper and lower endoscopy are required to locate the source (e.g., peptic ulcer, angiodysplasia, malignancy)【67】.
Ferritin ≈ 20 ng/mL confirms depleted iron stores (threshold < 30 ng/mL), although concurrent inflammation may falsely elevate the value, indicating even more severe iron deficiency【67】.
In patients over 80 years receiving anticoagulants, occult GI bleeding accounts for the majority of iron‑deficiency cases, making it the most common etiology in this demographic【67】.
Elevated C‑reactive protein together with low‑normal ferritin suggests a coexisting anemia of chronic disease, but the profound microcytosis and extremely low hemoglobin favor predominant iron deficiency【67】.
In inflammatory states, ferritin up to 100 µg/L may still be compatible with iron deficiency; a transferrin saturation < 16–20 % would further support this diagnosis【67】.
Chronic kidney disease contributes to anemia via reduced erythropoietin production and functional iron deficiency, but it does not explain the severe microcytosis observed【67】.

Endoscopic Evaluation

Upper endoscopy with duodenal biopsies should be performed urgently to detect peptic ulcer disease, gastric cancer, NSAID‑induced gastropathy, or angiodysplasia—common lesions in elderly anticoagulated patients【67】.
Colonoscopy is essential because colonic carcinoma, adenomatous polyps, and angiodysplasia are frequent findings in patients > 80 years with iron‑deficiency anemia【67】.
Duodenal biopsies also screen for celiac disease, which accounts for 2–3 % of iron‑deficiency anemia cases and may present with isolated anemia【67】.

Anticoagulation Considerations

Apixaban (110 mg twice daily) markedly raises bleeding risk from any mucosal lesion; however, the medication should not be discontinued for endoscopic procedures unless active hemorrhage is present, because the cardiovascular risk of stopping therapy outweighs procedural bleeding risk【67】.

Cardiac Consequences of Severe Anemia

High BNP levels, bilateral lung crepitations, and tachypnea indicate high‑output heart failure secondary to severe anemia rather than primary cardiac disease【68】.
A systolic murmur heard throughout the precordium represents a flow murmur generated by the hyperdynamic circulation needed to compensate for the critically low oxygen‑carrying capacity【68】.
Transient troponin I elevation reflects demand ischemia caused by severe anemia, not an acute coronary syndrome【68】.

Immediate Management

Urgent packed red blood cell transfusion to raise hemoglobin above 7 g/dL (target 7–9 g/dL in elderly patients with cardiac symptoms) should be performed before endoscopic evaluation【67】.
Upper endoscopy with duodenal biopsies and colonoscopy should be scheduled within 24–48 hours after hemodynamic stabilization to identify and treat the bleeding source【67】.
Intravenous iron therapy (e.g., iron sucrose or ferric carboxymaltose) may be administered after endoscopy if malabsorption is identified or oral iron fails, with an expected hemoglobin increase of ≥ 2 g/dL within 4 weeks【67】.

Diagnostic Pitfalls to Avoid

Do not attribute melena solely to oral iron supplementation, as this delays recognition of life‑threatening GI bleeding in anticoagulated elderly patients【67】.
Do not postpone endoscopic investigation to “optimize” the patient with iron therapy alone; the bleeding source must be identified promptly to prevent recurrent hemorrhage and mortality【67】.
Do not assume a ferritin of 20 ng/mL excludes severe iron deficiency when inflammation is present; true iron stores are likely even lower【67】.
Do not overlook the possibility of combined nutrient deficiencies; assessment of vitamin B12 and folate is advisable, although severe microcytosis makes megaloblastic anemia less likely【67】.
Do not discontinue apixaban for endoscopy unless active bleeding is ongoing, because the risk of thromboembolic events outweighs procedural bleeding risk【67】.

Diagnosis and Management of Iron‑Deficiency Anemia in Adolescents

Laboratory Evaluation

Serum ferritin is the most reliable single test for confirming iron deficiency; a level < 30 µg/L indicates depleted iron stores, while a cut‑off of 45 µg/L offers optimal sensitivity and specificity in clinical practice. [69][70]
The presence of microcytosis (2+) together with hypochromasia (2+) is the classic laboratory signature of iron‑deficient erythropoiesis and typically appears before hemoglobin falls below the anemia threshold. [69][70]

First‑Line Diagnostic Strategy

Order serum ferritin and transferrin saturation immediately to confirm iron deficiency; if ferritin is low or transferrin saturation is < 16–20 %, iron deficiency is established, and the underlying cause should be investigated concurrently. [69][70]

Immediate Treatment Protocol

Begin oral iron supplementation with ferrous sulfate 325 mg taken once to three times daily. A rise in hemoglobin of ≥ 10 g/L within 2 weeks confirms iron‑deficiency anemia even when initial iron studies are equivocal. [69][70]
In parallel, treat severe vitamin D deficiency (serum 25‑OH‑D ≈ 12 ng/mL) with cholecalciferol 50,000 IU weekly for 8 weeks, followed by maintenance dosing. [69][70]

Evidence‑Based Guidelines for Diagnosis and Management of Iron‑Deficiency Anemia

Diagnostic Confirmation

Serum ferritin < 30 µg/L confirms depleted iron stores; a cut‑off of 45 µg/L provides optimal sensitivity and specificity for routine screening. 71
Ferritin < 15 µg/L yields 99 % specificity for absolute iron deficiency, eliminating the need for additional iron studies. 71
When ferritin is 30–100 µg/L, concurrent measurement of C‑reactive protein and calculation of transferrin saturation (TSAT = serum iron × 100 ÷ TIBC) is recommended because ferritin may be falsely elevated by inflammation, infection, malignancy, or liver disease. 71
TSAT < 20 % confirms iron deficiency even when ferritin appears normal due to inflammatory states. 71
A hemoglobin increase of ≥10 g/L within two weeks after initiating therapy confirms iron deficiency when baseline iron studies are equivocal. 71

Indications and Dosing for Intravenous Iron

Switch to intravenous iron (iron sucrose, ferric carboxymaltose, or iron gluconate) if oral iron does not raise hemoglobin by ≥2 g/dL within four weeks, if malabsorption is documented, or if gastrointestinal side effects prevent adherence. 72
Total IV iron requirement should be calculated using a formula that accounts for the hemoglobin deficit and the need to replenish iron stores; the cumulative dose is administered in divided infusions every 3–7 days until the target is reached. 72
Each IV iron infusion must not exceed the product‑specific maximum single‑dose limit. 72
Serum ferritin should be monitored during IV therapy and kept below 500 µg/L to avoid iron overload, especially in children and adolescents. 72
In iron‑refractory iron‑deficiency anemia caused by TMPRSS6 mutations, oral iron is ineffective and intravenous iron is required. 72

Investigation of Underlying Cause

Adults (men with hemoglobin < 110 g/L; non‑menstruating women with hemoglobin < 100 g/L) should receive expedited bidirectional endoscopy (upper endoscopy with duodenal biopsies plus colonoscopy) to evaluate for gastrointestinal malignancy and other sources of blood loss. 71
The probability of serious gastrointestinal pathology rises with greater anemia severity, supporting endoscopic evaluation at any anemia grade when iron deficiency is confirmed. 71
Upper endoscopy with duodenal biopsies screens for celiac disease (prevalence ≈ 2–3 % in iron‑deficiency cases), gastric cancer, peptic ulcer disease, and NSAID‑induced gastropathy. 71, 73
Colonoscopy detects colonic carcinoma, adenomatous polyps, angiodysplasia, and inflammatory bowel disease as potential bleeding sources. 71, 73

Clinical Pitfalls and Management Principles

Occult gastrointestinal blood loss must be excluded before attributing iron deficiency to dietary insufficiency. 71
In the presence of inflammation, ferritin alone is insufficient; TSAT should be calculated to identify functional iron deficiency. 71
Iron supplementation should continue after hemoglobin normalization until ferritin exceeds 50 µg/L to replenish stores and prevent recurrence. 71
Combined micronutrient deficiencies (e.g., vitamin B12 or folate) may coexist with iron deficiency and can be suggested by an elevated red‑cell distribution width. 71
In patients with chronic kidney disease, chronic heart failure, or inflammatory bowel disease, a ferritin threshold < 100 µg/L (instead of < 30 µg/L) is recommended for screening iron deficiency. 71

Sideroblastic Anemia – Diagnostic and Management Guidance

Diagnostic Features

Sideroblastic anemia is characterized by high serum ferritin and high transferrin saturation; when a patient with microcytic anemia does not improve with oral iron therapy, a bone‑marrow examination for ring sideroblasts should be performed to confirm the diagnosis. 74

Microcytosis as an Early Indicator of Iron Deficiency in Children

Diagnostic Criteria

In pediatric patients, a mean corpuscular volume (MCV) of 79 fL falls below the normal age‑specific range of 80–100 fL and therefore signifies microcytosis, which reflects the onset of iron‑deficient erythropoiesis even when hemoglobin levels remain normal. 75